|
Age (years)
|
|
Range
|
(45–68)
|
(42–72)
|
0.274
|
|
Mean ± SD
|
58.05 ± 5.91
|
56.43.1 ± 7.75
|
|
Sex (frequency)
|
|
Male
|
58 (48.3%)
|
30 (50%)
|
0.881
|
|
Female
|
62 (51.7%)
|
30 (50%)
|
|
Weight (kg)
|
|
Range
|
(67–98)
|
(65–95)
|
0.239
|
|
Mean ± SD
|
81.5 ± 7.31
|
79.53 ± 7.65
|
|
Height (cm)
|
|
Range
|
(154–180)
|
(155–175)
|
0.756
|
|
Mean ± SD
|
164.65 ± 6.51
|
164.2 ± 6.38
|
|
Body surface area (m2)
|
|
Range
|
1.92 ± 0.09
|
1.9 ± 0.1
|
0.141
|
|
Mean ± SD
|
(1.69–2.09)
|
(1.73–2.1)
|
|
BMI (kg/m2)
|
|
Range
|
(22.84–38.05)
|
(24.45–35.3)
|
0.435
|
|
Mean ± SD
|
30.19 ± 3.49
|
29.59 ± 3.35
|
|
Serum creatinine (mg/dl)
|
|
Range
|
(0.78–2.3)
|
(0.45–0.8)
|
< 0.001*
|
|
Mean ± SD
|
1.31 ± 0.35
|
0.64 ± 0.1
|
|
Blood Urea (mg/dl)
|
|
Range
|
(1.38–137.23)
|
(18–40)
|
< 0.001*
|
|
Mean ± SD
|
44.83 ± 22.06
|
27.03 ± 5.32
|
|
Serum cystatin C (μg/L)
|
|
Range
|
(0.9–4.2)
|
(0.55–1.1)
|
< 0.001*
|
|
Mean ± SD
|
1.79 ± 0.61
|
0.72 ± 0.11
|
|
Serum sodium (mEq/L)
|
|
Range
|
(128–153)
|
(134–145)
|
0.155
|
|
Mean ± SD
|
138.9 ± 4.34
|
137.67 ± 2.55
|
|
Serum potassium (mEq/L)
|
|
Range
|
(3–6)
|
(3.40–4.50)
|
0.005*
|
|
Mean ± SD
|
4.06 ± 0.47
|
3.85 ± 0.21
|
|
Fasting plasma glucose (mg/dl)
|
|
Range
|
(65–110)
|
(75–100)
|
0.155
|
|
Mean ± SD
|
83.22 ± 11.55
|
86 ± 6.78
|
|
2 h postprandial plasma glucose (mg/dl)
|
|
Range
|
(3.80–140)
|
(96–120)
|
0.002*
|
|
Mean ± SD
|
115.91 ± 23.3
|
105.57 ± 6.16
|
|
RBCs (× 106/mm3)
|
|
Range
|
(2.25–5.5)
|
(3.9–6.2)
|
< 0.001*
|
|
Mean ± SD
|
3.61 ± 0.6
|
5.17 ± 0.59
|
|
HB (g/dl)
|
|
Range
|
(5.8–15.1)
|
(8.6–15)
|
< 0.001*
|
|
Mean ± SD
|
9.89 ± 1.79
|
12.6 ± 1.43
|
|
aPlatelets (× 103/mm3)
|
|
Median
|
113.5
|
330.5
|
< 0.001*
|
|
IQR
|
(92–180.5)
|
(289–361)
|
|
WBCs (× 103/mm3)
|
|
Range
|
(2.90–11.2)
|
(3.4–8.4)
|
0.554
|
|
Mean ± SD
|
6.24 ± 2.03
|
6 ± 1.4
|
|
aTotal bilirubin (mg/dl)
|
|
Median
|
1.5
|
0.4
|
< 0.001*
|
|
IQR
|
(1.1–2.4)
|
(0.3–0.4)
|
|
aDirect bilirubin (mg/dl)
|
|
Median
|
0.8
|
0.2
|
< 0.001*
|
|
IQR
|
(0.4–1)
|
(0.2–0.3)
|
|
aAST (IU/L)
|
|
Median
|
54.5
|
22
|
< 0.001*
|
|
IQR
|
(39.4–84)
|
(18–24)
|
|
aALT (IU/L)
|
|
Median
|
44.5
|
23.5
|
< 0.001*
|
|
IQR
|
(32.5–67.2)
|
(22–27)
|
|
Albumin (g/dl)
|
|
Range
|
(1.5–4.85)
|
(4.18–4.9)
|
< 0.001*
|
|
Mean ± SD
|
2.63 ± 0.64
|
4.56 ± 0.24
|
|
INR
|
|
Range
|
(1.03–2.85)
|
(0.98–1.02)
|
< 0.001*
|
|
Mean ± SD
|
1.63 ± 0.53
|
1 ± 0.01
|
|
Creatinine clearance (ml/min per 1.73 m2)
|
|
Range
|
(20–87.8)
|
(85–138)
|
< 0.001*
|
|
Mean ± SD
|
51.39 ± 16.05
|
113.9 ± 12.74
|
|
Cockcroft-Gault formula (ml/min per 1.73 m2)
|
|
Range
|
(33–108)
|
(69–202)
|
< 0.001*
|
|
Mean ± SD
|
70.33 ± 20.4
|
121.17 ± 38.29
|
|
MDRD (ml/min per 1.73 m2)
|
|
Range
|
(25–98)
|
(88–225)
|
< 0.001*
|
|
Mean ± SD
|
52.78 ± 15.84
|
126.83 ± 29.14
|
|
CKD-EPI (ml/min per 1.73 m2)
|
|
Range
|
(26–95)
|
(103–155)
|
< 0.001*
|
|
Mean ± SD
|
56.1 ± 17.24
|
121.4 ± 12.04
|
|
CKD-EPI creatinine-cystatin C (ml/min per 1.73 m2)
|
|
Range
|
(16–79)
|
(97–161)
|
< 0.001*
|
|
Mean ± SD
|
45.95 ± 14.82
|
123.77 ± 14.52
|
|
CKD-EPI cystatin C (ml/min per 1.73 m2)
|
|
Range
|
(11–87)
|
(78–164)
|
< 0.001*
|
|
Mean ± SD
|
40.55 ± 16.68
|
119.57 ± 16.86
|
